Mark Greenberg
About Mark Greenberg
Mark Greenberg (age 71) is an independent director of Quipt Home Medical Corp. (QIPT) serving since December 21, 2017; he is the Board’s Lead Independent Director and Chair of the Nominating and Corporate Governance Committee, and sits on the Audit and Compensation Committees . He is Managing Partner and Founder of Silverstone Capital Advisors (since March 2009), with more than 30 years of senior operating and transaction experience and participation in 150+ M&A and capital sourcing transactions; he previously was Managing Partner at Ludlow, Ward & Greenberg Capital Partners (2005–2009), and has served as CEO/Chairman of privately held companies and division-level president at Fortune 500 firms . He has taught graduate-level M&A at the University of Cincinnati and received the Association for Corporate Growth Lifetime Achievement Award in 2024 .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Silverstone Capital Advisors | Managing Partner & Founder | Mar 2009–present | Principal investor/advisor; 150+ M&A and financing transactions |
| Ludlow, Ward & Greenberg Capital Partners | Managing Partner | 2005–2009 | Investment/transaction leadership |
| Various privately held companies | CEO/Chairman | Various | Operational leadership (middle-market, high-growth VC-backed) |
| Fortune 500 company units | Division-level President | Various | Senior operating leadership |
| University of Cincinnati (Lindner Graduate School of Business) | Adjunct Professor (Graduate M&A course) | 6 years | Graduate-level M&A education |
External Roles
| Organization | Role | Scope |
|---|---|---|
| Association for Corporate Growth | Lifetime Achievement Award Recipient (2024) | National recognition in dealmaking community |
| University of Cincinnati | Adjunct Professor (Graduate M&A) | Academic instruction in M&A |
Board Governance
- Independence: Board determined Greenberg is independent under NI 58-101 and Nasdaq rules .
- Lead Independent Director: Serves as LID; presides over executive sessions and liaises between independent directors and CEO/Chairman .
- Committee memberships/chairs: Audit (member), Compensation (member), Nominating & Corporate Governance (Chair; established Oct 1, 2024) .
- Attendance (FY2024): Board 4/4; Audit 4/4; Compensation 4/4; independent directors held executive sessions at each of the four Board meetings .
- Other public boards: None of QIPT’s directors currently serve on other reporting issuers in Canada/US .
- Board size/structure: 4 directors; CEO serves as Chairman; independent directors met 4 times without management .
| Governance Attribute | Status |
|---|---|
| Independence | Independent |
| Lead Independent Director | Yes (Greenberg) |
| Audit Committee | Member |
| Compensation Committee | Member |
| Nominating & Corporate Governance Committee | Chair (est. Oct 1, 2024) |
| FY2024 Attendance | Board 4/4; Audit 4/4; Comp 4/4 |
| Executive Sessions (FY2024) | 4 independent director sessions |
| Other public company directorships | None disclosed |
Fixed Compensation
| Director | Cash Fees (FY2024) | Share-Based Awards (FY2024) | Option Awards (FY2024) | Other/Meeting Fees |
|---|---|---|---|---|
| Mark Greenberg | $150,000 | — | — | No meeting fees; reimbursed travel/misc expenses |
Independent directors did not receive meeting fees; they are reimbursed for travel/miscellaneous expenses .
Performance Compensation
- No performance-based or equity grants to directors were made in FY2024 under the 2024 EIP; “no grants were awarded under the 2024 EIP” for the year ended September 30, 2024 .
- No director-specific performance metrics (e.g., TSR, EBITDA) tied to compensation are disclosed.
Other Directorships & Interlocks
| Category | Detail |
|---|---|
| Current public company boards | None disclosed for QIPT directors |
| Committee positions at other public companies | Not applicable |
| Interlocks with QIPT competitors/suppliers/customers | None disclosed |
Expertise & Qualifications
- M&A and capital markets: Principal/advisor/banker on 150+ transactions; deep experience in equity/debt funding and distressed M&A .
- Operating leadership: CEO/Chairman in privately held firms; division-level president in Fortune 500 units .
- Academic: Adjunct professor teaching graduate-level M&A .
- Financial literacy: All Audit Committee members (including Greenberg) are independent and financially literate under NI 52-110; Wessel designated audit committee financial expert; Greenberg serves on Audit Committee .
Equity Ownership
| Metric | Amount |
|---|---|
| Total beneficial ownership (shares) | 782,440 |
| Ownership as % of outstanding | 1.8% (based on 43,091,273 shares) |
| Options (exercisable or vesting within 60 days) | 488,750 |
| RSUs vested (issuable on or before Mar 15, 2025) | 92,500 |
| Unvested RSUs (as of 9/30/2024) | 46,250 |
| Shares pledged as collateral | None (company-wide disclosure) |
Outstanding director awards held as of September 30, 2024: Mark Greenberg RSUs 46,250; options 488,750 . Beneficial ownership includes rights to acquire within 60 days under SEC rules; RSUs vested in calendar 2024 are deliverable by March 15, 2025 .
Governance Assessment
- Board effectiveness: Greenberg’s dual roles as Lead Independent Director and Nominating Committee Chair enhance independent oversight (executive sessions held at each Board meeting in FY2024) and governance processes (committee charter covers board evaluations, succession planning, ESG oversight, and governance framework) .
- Independence and engagement: Full attendance across Board and key committees in FY2024 signals strong engagement; independence affirmed under NI 58-101 and Nasdaq .
- Ownership alignment: Meaningful beneficial ownership (1.8%) with a mix of options and RSUs; company policy prohibits hedging/shorting/derivatives and pledging, and no pledging is disclosed, supporting alignment with shareholders .
- Compensation structure: FY2024 director pay was cash-only (no equity grants), while prior equity holdings exist; absence of equity grants in FY2024 under the EIP may modestly reduce incremental alignment created by new grants, though existing holdings partially offset this .
- Conflicts/related-party exposure: No related-party transactions involving Greenberg disclosed; company reviews/approves related-party transactions via the Audit Committee; disclosed related-party leases involve CEO (not Greenberg) and are overseen under the related-party review policy .
- Risk indicators: No legal penalties/sanctions, cease trade orders, or personal bankruptcies for proposed directors; D&O insurance in place ($25M aggregate) .
RED FLAGS
- None disclosed specific to Mark Greenberg: no related-party transactions, no pledging of shares, full attendance, independent status .
Contextual note
- Board size is four, and the CEO is Chairman; Lead Independent Director structure and committee independence (Audit, Compensation, Nominating) mitigate concentration of authority .